A detailed history of Aberdeen Wealth Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Aberdeen Wealth Management LLC holds 12,995 shares of ABBV stock, worth $2.34 Million. This represents 1.72% of its overall portfolio holdings.

Number of Shares
12,995
Previous 14,992 13.32%
Holding current value
$2.34 Million
Previous $2.57 Million 0.19%
% of portfolio
1.72%
Previous 1.76%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$163.84 - $199.33 $327,188 - $398,062
-1,997 Reduced 13.32%
12,995 $2.57 Million
Q2 2024

Aug 02, 2024

BUY
$154.79 - $180.76 $8,203 - $9,580
53 Added 0.35%
14,992 $2.57 Million
Q1 2024

May 14, 2024

BUY
$159.82 - $182.1 $240,209 - $273,696
1,503 Added 11.19%
14,939 $2.72 Million
Q4 2023

Feb 14, 2024

SELL
$137.6 - $154.97 $212,867 - $239,738
-1,547 Reduced 10.33%
13,436 $2.08 Million
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $400 - $463
3 Added 0.02%
14,983 $2.23 Million
Q2 2023

Aug 03, 2023

BUY
$132.51 - $164.9 $397 - $494
3 Added 0.02%
14,980 $2.02 Million
Q1 2023

May 15, 2023

SELL
$144.61 - $166.54 $14,027 - $16,154
-97 Reduced 0.64%
14,977 $2.39 Million
Q4 2022

Feb 14, 2023

SELL
$138.31 - $165.87 $270,672 - $324,607
-1,957 Reduced 11.49%
15,074 $2.44 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $402 - $461
3 Added 0.02%
17,031 $2.29 Million
Q2 2022

Aug 10, 2022

BUY
$137.62 - $174.96 $412 - $524
3 Added 0.02%
17,028 $2.61 Million
Q1 2022

May 12, 2022

BUY
$131.98 - $163.75 $395 - $491
3 Added 0.02%
17,025 $2.76 Million
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $322 - $407
3 Added 0.02%
17,022 $2.31 Million
Q3 2021

Nov 15, 2021

SELL
$106.4 - $120.78 $31,068 - $35,267
-292 Reduced 1.69%
17,019 $1.84 Million
Q2 2021

Jul 23, 2021

BUY
$105.21 - $117.21 $315 - $351
3 Added 0.02%
17,311 $1.95 Million
Q1 2021

May 13, 2021

SELL
$102.3 - $112.62 $42,966 - $47,300
-420 Reduced 2.37%
17,308 $1.87 Million
Q4 2020

Feb 10, 2021

BUY
$80.49 - $108.67 $33,805 - $45,641
420 Added 2.43%
17,728 $1.9 Million
Q3 2020

Nov 13, 2020

BUY
$85.91 - $100.83 $343 - $403
4 Added 0.02%
17,308 $1.52 Million
Q2 2020

Aug 13, 2020

BUY
$73.37 - $98.18 $4,108 - $5,498
56 Added 0.32%
17,304 $1.7 Million
Q1 2020

May 08, 2020

SELL
$64.5 - $97.79 $14,835 - $22,491
-230 Reduced 1.32%
17,248 $1.31 Million
Q4 2019

Feb 14, 2020

BUY
$72.13 - $90.25 $1.26 Million - $1.58 Million
17,478 New
17,478 $1.55 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Aberdeen Wealth Management LLC Portfolio

Follow Aberdeen Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aberdeen Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aberdeen Wealth Management LLC with notifications on news.